Connect with us

Business

Credence launches the COVID Diagnostics Center

Published

on

Credence Genomics, trail blazers in the area of genome diagnostics, has launched the COVID Diagnostics Center to cater for the needs of COVID RT-qPCR testing in Sri Lanka. The company announced last week.

The COVID Diagnostics Center is a diagnostic grade facility with the capacity to deliver over 6,000 tests, a four- hour reporting time and a lab time of 70 mins. Credence CDC President Dr. Sarath Paranavitane, an industry veteran who has been involved in many important local and international healthcare projects  that cater to high quality testing and patient care, who will be heading the Centre said. 

“The vision behind the COVID Diagnostics Center (CDC) is to serve the need for rapid high quality PCR testing where a patient can conduct the gold standard qPCR test within three hours based on enhanced technology investments. The unit uses robotic magnetic bead extractors from Pentabase Denmark, a leader in RNA extraction and qPCR. The units are used in major airports, and health institutions including Sri Lanka’s BIA lab which conducted 100,00 tests on this  platform recently”, said Paranavitane.

Credence CDC also uses diagnostic grade approved RT-qPCR machines from leading suppliers in a purpose-built facility designed specifically to prevent contamination, while  a team of award-winning Lankan scientists with global delivery experience is behind every single test. The facility follows strict decontamination and fogging protocols ensuring the integrity of the unit and in turn each sample, a news release said.

“Each sample is registered online, and sample integrity is checked through multiple quality control parameters, while Credence only works with collectors who are evaluated and certified by a consultant microbiologist or virologist”.

Paranavitane went on to say that the COVID Diagnostic Center has been conceived to respond to the national need for high quality, rapid, and precise PCR testing. An early test result will enable  the Sri Lankan  workforce to take prompt  action in keeping with the government guidelines which in turn will help the workforce to return to work early and ensure smooth functioning of the organization.

“A test of this speed, accuracy and cost effectiveness will reduce the government burden by encouraging early home isolation and also curtail spread of COVID 19.”

The uniqueness of the Credence lab vis-a- vis other facilities includes the fact that it is the only facility that could perform 6,000 tests per day and give a report in four hours, the entire process from collection point to generation of a report can be viewed on line by an access given from  a dedicated portal, and all tests are done on a diagnostic platform as opposed to a research platform with no pooling of samples.

The process is automated with minimal human interaction thereby ensuring 100 % accuracy. Every report  carries the CT value in compliance with WHO and CDC  guidelines, while the team of collectors are trained and certified by a consultant microbiologist and consultant physician [Dr Paranavitane] on an ongoing basis, with weekly reviews.

 “Collection of samples as you are aware is the first most important step in this process of PCR testing as if this is  not done properly, the subsequent steps  leading  to report generation becomes a futile exercise” said Paranavitane.

CEO, Credence Genomics Dr. Vaz Gnanam  said “the COVID Diagnostic Center is an amalgamation of scientists, healthcare professionals, and the most advanced technology along with data systems and processes under the exemplary leadership of Dr. Sarath Paranavitane  in response to the national crisis caused by COVID. Credence Genomics considers it  a privilege to serve our nation at this time of crisis.

Dr. Vaz Gnanam futher said that Credence Genomics is honoured to join hands with the Central Medical Centre (PVT) Ltd. at Kohuwala – a longstanding and reputed family practice of Dr.Sarath Paranavitane’s to take forward the concept of next generation sequencing in cancer management at both primary and secondary healthcare levels

Credence Genomics (Pvt) Limited is Sri Lanka’s first and foremost clinical genomics laboratory to provide high throughput, high quality next generation sequencing services. Credence Genomics services both international and local genetic testing markets by exporting high quality testing services and products. A long term collaboration with Apollo Hospitals in India , has seen Credence’s unique infectious disease Bactfast and Fungifast being used across the board at arguably  the largest South Asian healthcare services provider. Credence Genomics has forged many partnerships globally and delivers their oncology and fertility range apart from the award winning dxn1 – infectious disease range.

 

 



Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Business

HNBA Group records impressive 3Q22 results

Published

on

HNB Assurance PLC (HNBA) and its fully owned subsidiary HNB General Insurance Limited (HNBGI) reported a consolidated Gross Written Premium (GWP) of Rs 11.3 Bn marking a steady growth of 26% and a consolidated Profit After Tax (PAT) of Rs 1.5 Bn marking a growth of 228% during the nine months ended 30th September 2022 compared to the comparative period last year.

A press release from HNBA said:. Rose Cooray Chairperson of HNBA and HNBGI, expressed her views on the financial performance of the Group stating, “despite of the negative impact caused by the economic turbulence of the country and the challenges faced, both companies have performed extremely well in terms of both topline and bottom line. Both HNBA and HNBGI were able to increase their respective market shares by growing well above the market averages. Group PBT grew by 167% for the period reaching Rs 1.9 Bn compared to Rs 731.4 Mn in the corresponding period last year. The key reason for the exceptional growth is the transfer of Rs 1.1 Bn surplus from Life policyholders fund, subsequent to the valuation of the Life Fund as at 30th September 2022. It must be noted that no surplus transfer from Life policyholders was made in 3Q 2021 as it was done in December 2021.These profits posted were after incurring Rs 4 Bn as Net Insurance Benefits and Claims to our policyholders in 2022, compared to Rs 2.9 Bn in the corresponding period. The Group’s strategic emphasis is on increasing growth across key products and services while delivering a superior customer service through digital enablement and process efficiency”.

Sharing his views, Chief Executive Officer of HNBA Lasitha Wimalaratne said: “I am happy to note that the resilience of our core business model has led to yield these remarkable results despite the challenges we had to face in the previous months. While the business keeps retooling itself with tech transformations and keeping abreast of market trends, HNBA’s GWP increased by 32% achieving Rs 6.6 Bn. HNBA posted a PAT of Rs 1.2 Bn recording a 483% growth with the surplus transfer from the Life Fund. The Company’s Life Insurance Fund stands at Rs 23.1 Bn at the end of Q3 of 2022. Contributing to this momentum HNBA’s Capital Adequacy Ratio (CAR) stood at 283%”.

HNBA is the only insurance company to be listed amongst the Top 70 Best

Workplaces in Asia whilst also being recognised amongst the Top 50 Best Workplaces in Sri Lanka. The Company was also awarded as the best Digital Marketing Brand in the Insurance Industry and was recognised as the best Bancassurance team for two consecutive years by Global Banking and Finance Review. Wimalaratne also extended his sincere appreciation to the Agency and Partnership Channels, Support service teams and the HNB Management for their contribution to deliver these impressive results.

Commenting on these results, Chief Executive Officer of HNBGI Sithumina Jayasundara ssid that “the company was able to maintain a sustainable financial growth in 2022 compared to 2021 and that he is confident with the solid business strategies in place, the business will continue to grow to greater heights. Appreciating the dedication and efforts of both Strategic Business Units, Support Services and Operations Units, Mr. Jayasundara also stated that the business delivered a great performance during Q3 2022 recording a GWP of Rs. 4.8 Bn. Further reviewing the performance of the business, HNBGI recorded PAT of Rs. 417.6 Mn compared to Rs. 372.2 Mn last year. The Company’s Capital Adequacy Ratio (CAR) stood at 266% well above the regulatory requirement”.

Continue Reading

Business

New IFC Country Manager to focus on spurring resilient private sector-led growth

Published

on

IFC has appointed Alejandro Alvarez de la Campa as the new Country Manager for Sri Lanka and Maldives. Based in Colombo, Alvarez de la Campa will lead IFC’s strategy in building a diversified portfolio and increasing impact in both countries, while helping strengthen sustainable private sector development to promote inclusive growth, an IFC news release said.

A Spanish national, Alvarez de la Campa joined IFC in 2004, and has extensive experience working across the World Bank Group. Prior to this appointment, he was the Manager leading IFC’s Creating Markets Advisory teams in Africa, Latin America, and the Middle East, in charge of strategic engagements with governments and private sector partners to improve the investment climate across regions and industries.

Alvarez de la Campa was also a Practice Manager for Finance, Competitiveness and Innovation (FCI) and Finance and Markets (F&M) in Africa in the joint World Bank-IFC Global Practice group, the release said.His appointment comes at a significant time for Sri Lanka when the country needs to spur private sector-led growth to navigate the ongoing economic fallout, it said.

“With Sri Lanka’s economy expected to contract by 9.2 percent this year and a further 4.2 percent in 2023, it’s vital to work to spur the financial resources and expertise of the private sector to help the country on the long road to recovery,” said Hector Gomez Ang, IFC Regional Director for South Asia. “With the right reforms in place, IFC in Sri Lanka under the leadership of Alvarez de la Campa is determined to play its part in helping spur investments and create jobs.”

Bringing years of experience leading teams who supported policy implementation and reforms for private-sector-led development, Alvarez de la Campa’s top priority will be to strategically lead IFC’s investment and advisory engagements in Sri Lanka, pushing for stronger, progressive steps towards improving private sector-led growth to create jobs and opportunities for people.

“As the Country Manager for IFC in Sri Lanka and Maldives, I am looking forward to continuing and scaling up IFC’s impact in Sri Lanka while also strengthening our engagements with the private sector, government and development partners,” said Alejandro Alvarez de la Campa. “We know from our experience, a stronger private sector leads to increased economic opportunities, and IFC is well positioned to support Sri Lanka through these critical times.”

“I believe that no crisis is the same, and that out of crises can emerge opportunities which cannot be wasted,” he said. “One of the greatest assets of Sri Lanka is the resilience of its people. Despite economic and political headwinds over the years, Sri Lankans have always shown their strength in building back better. We are well aware of that and IFC will continue to support the country, building new partnerships to pave the way for a more sustainable, resilient, and inclusive future.”

Alvarez de la Campa holds a Law Degree (JD) from the University of Seville and an MSc in Innovation and Entrepreneurship from HEC Paris.

With over 50 years of operations in Sri Lanka, IFC has played a significant role in the country’s growth story by supporting small businesses, tourism, women, including women entrepreneurs, infrastructure, trade finance, and agribusiness. In Sri Lanka, IFC has invested over $1.9 billion across sectors including infrastructure, telecom, tourism, energy, and health, while providing cutting-edge solutions and expertise to diverse clients across the country.

Continue Reading

Business

Ceylon Spice Company: In partnership with Sri Lankan Spice Industry

Published

on

With internationally-acclaimed Dilmah already producing what the company claims to be Ceylon’s Finest Single Origin Teas, “The Ceylon Spice Company (Pvt) Ltd” a subsidiary of MJF Group – was founded to support the spice industry in local value addition.

“CSC’s mission is to become the service provider of choice offering state of the art technologies under one roof, accredited laboratory facilities, expert raw material handling and customer care to all local spice exporters and enhance Sri Lanka’s image as a global spice sourcing destination of choice for safe and quality herbs and spices. CSC believes that the mutual benefits gained in terms of wider customer base and premium prices for exporters will create a sustainable business model going forward,” a news release said.

“CSC works closely with local spice exporters, farmers and entrepreneurs offering milling facilities with cooling to minimize volatile oil losses during grinding and European patented Steam Sterilization technology SAFESTERIL® which consist of Spirajoule® (an electrical heating system which could be used for sterilization, drying, roasting, toasting and pre-cooking), and UPX® a patented flash cooler from ETIA France, in addition to providing bulk and value packing options to their customers all under one roof.

“The process of continuous steam sterilization used at CSC is the safest internationally approved method to reduce microbe counts to safe levels, yielding consistent results using an electrically heated screw along with saturated steam, superheated dry steam, or no steam at all – depending on the degree of contamination. The Sterilization unit provides a homogenous, efficient and effective treatment via excellent product mixing mechanisms and use quick product cooling chambers ensuring minimum process & volatile oil losses with minimum organoleptic changes in products.

“The CSC handles a wide range of granular and whole forms of spices, herbs and botanicals including dried fruit and seeds, black & green teas, cereals, herbs and spices, dried vegetables, botanicals, nuts and desiccated coconut, among others,” it added.

In addition to Steam Sterilization of all the powdered, granular and whole spices & herbs listed above, CSC also provides further treatments. This includes blanching and roasting of the products, fine grinding facilities including powdering ‘super-fine’ grade products such as Green Matcha, fine Cinnamon Powder and all leaf-type spices, as well as the processing of ground Cinnamon, Black Pepper, Ginger, Turmeric, among other spices. Additionally, CSC offers pre-cutting facilities (size range 2mm – 15mm) and currently supplies 100% Dilmah’s requirements and bulk and value packing options with material supplied by the customer, the release further said.

“SAFESTERIL system offers an environmentally friendly and cost-effective decontamination solution with all equipment being externally validated by multiple external laboratories.”

The Ceylon Spice Company is backed by the accredited laboratory facilities at Dilmah and expert Food Technologists who screens all raw material and finished product’s organoleptic and microbial parameters accompanied by comprehensive reports for each batch. CSC’s highly experienced and trained team has successfully processed over 1,000 metric tons of assorted spices with the help of their state-of-the-art facilities,” the release concluded.

Continue Reading

Trending